Alzheimer’s Disease

Predicting seizures in patients with dementia 1:18
Predicting seizures in patients with dementia
Ifrah Zawar • 2 Dec 2022
Comorbid seizures in dementia lead to worse clinical outcomes and higher mortality rates 3:58
Comorbid seizures in dementia lead to worse clinical outcomes and higher mortality rates
Ifrah Zawar • 2 Dec 2022
Cerebral microbleeds and cognitive decline 2:07
Cerebral microbleeds and cognitive decline
Hsin-Hsi Tsai • 31 Oct 2022
Alterations of the salience/midcingulo-insular network across pathologies 1:53
Alterations of the salience/midcingulo-insular network across pathologies
Lucina Qazi Uddin • 19 Oct 2022
Novel approaches in targeting specific phenotypes for tauopathies 1:37
Novel approaches in targeting specific phenotypes for tauopathies
Rodolfo Savica • 16 Sep 2022
Current treatment options for neurodegenerative movement disorders 1:28
Current treatment options for neurodegenerative movement disorders
Rodolfo Savica • 16 Sep 2022
Functional imaging and tau PET tracers for diagnosing PSP & CBD 2:20
Functional imaging and tau PET tracers for diagnosing PSP & CBD
Rodolfo Savica • 16 Sep 2022
Evaluating the long-term cognitive effects of COVID-19 3:56
Evaluating the long-term cognitive effects of COVID-19
Jennifer Frontera • 3 Apr 2022
Improving brain waste clearance to treat CAA and Alzheimer’s disease 3:14
Improving brain waste clearance to treat CAA and Alzheimer’s disease
Roxana Carare • 4 May 2022
The impact of brain clearance systems on treatment success in neurodegenerative disease 2:32
The impact of brain clearance systems on treatment success in neurodegenerative disease
Roxana Carare • 4 May 2022
African ancestry specific locus reduces the effect of the ApoE ε4 allele in Alzheimer’s disease 5:42
African ancestry specific locus reduces the effect of the ApoE ε4 allele in Alzheimer’s disease
Farid Rajabli • 13 Apr 2022
ApoE in Alzheimer’s disease: knowns and unknowns 3:23
ApoE in Alzheimer’s disease: knowns and unknowns
Farid Rajabli • 13 Apr 2022
Is α-synuclein a useful therapeutic target in Parkinson’s disease? 4:31
Is α-synuclein a useful therapeutic target in Parkinson’s disease?
Amos Korczyn • 7 Mar 2022
Hippocampus atrophy and white matter lesions in PD & AD 2:15
Hippocampus atrophy and white matter lesions in PD & AD
Ivan Rektor • 17 Apr 2022
Hippocampal volume changes in Parkinson’s disease 2:05
Hippocampal volume changes in Parkinson’s disease
Ivan Rektor • 17 Mar 2022
The effects of Alzheimer’s disease pathophysiology on sleep-dependent memory 0:58
The effects of Alzheimer’s disease pathophysiology on sleep-dependent memory
Bryce Mander • 14 Mar 2022
The content of VJNeurology is intended for healthcare professionals